Literature DB >> 9115255

Phosphorylation and O-glycosylation sites of bovine chromogranin A from adrenal medullary chromaffin granules and their relationship with biological activities.

J M Strub1, O Sorokine, A Van Dorsselaer, D Aunis, M H Metz-Boutigue.   

Abstract

Bovine adrenal medullary chromogranin A, the major soluble component of chromaffin granules, is a phosphorylated glycoprotein. In the present work, phosphorylation and glycosylation sites were determined using mild proteolysis, peptide separation, microsequencing, and mass analysis by electrospray and matrix-assisted laser desorption ionization time-of-flight techniques. Seven post-translational modification sites were detected. Two O-linked glycosylation sites, each consisting of the trisaccharide NeuAcalpha2-3Galbeta1-3GalNAcalpha1, were located in the middle part of the protein, on Ser186 and on Thr231. The former residue is present in the antibacterial peptide named chromacin. Four phosphorylation sites were located on serine residues at positions Ser81 in the N-terminal region of the protein and Ser307, Ser372, and Ser376 in the C-terminal end. One additional phosphorylation site was found on the tyrosine residue at position Tyr173, the N-terminal amino acid of chromacin. With the exception of the phosphorylation on Tyr173, all of the other post-translational modifications are located on highly conserved chromogranin A regions, implying some biological importance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115255     DOI: 10.1074/jbc.272.18.11928

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Phosphorylation and Alternative Splicing of 7B2 Reduce Prohormone Convertase 2 Activation.

Authors:  Bruno Ramos-Molina; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2015-03-26

Review 2.  Secreted protein kinases.

Authors:  Vincent S Tagliabracci; Lorenzo A Pinna; Jack E Dixon
Journal:  Trends Biochem Sci       Date:  2012-12-29       Impact factor: 13.807

3.  The functional role of chromogranins in exocytosis.

Authors:  Natalia Domínguez; Judith Estévez-Herrera; Marta R Pardo; Daniel Pereda; José David Machado; Ricardo Borges
Journal:  J Mol Neurosci       Date:  2012-03-14       Impact factor: 3.444

4.  Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies.

Authors:  Andreas Tartaglia; Guida M Portela-Gomes; Kjell Oberg; Paolo Vezzadini; Maria P Foschini; Mats Stridsberg
Journal:  Virchows Arch       Date:  2006-01-12       Impact factor: 4.064

5.  Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies.

Authors:  Long Jin; Shuya Zhang; Jill Bayliss; Bernd Scheithauer; Xiang Qian; Ikuo Kobayashi; Mats Stridsberg; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245).

Authors:  F Degorce; Y Goumon; L Jacquemart; C Vidaud; L Bellanger; D Pons-Anicet; P Seguin; M H Metz-Boutigue; D Aunis
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

Review 7.  The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease.

Authors:  Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

8.  Targeting the glycoproteome.

Authors:  Jonas Nilsson; Adnan Halim; Ammi Grahn; Göran Larson
Journal:  Glycoconj J       Date:  2012-08-11       Impact factor: 2.916

9.  Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases.

Authors:  Rizwan Aslam; Céline Marban; Christian Corazzol; François Jehl; François Delalande; Alain Van Dorsselaer; Gilles Prévost; Youssef Haïkel; Corinne Taddei; Francis Schneider; Marie-Hélène Metz-Boutigue
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.